CIITA and neoplasm: Indeed, it was shown that CIITA-driven MHC-II-expressing tumor cells can play the role of surrogate APC for their own tumor antigens and trigger an adaptive response in vivo capable to reject the tumor as result of stimulation of tumor-specific TH cells which in turn is accompanied by a drastic modification of the tumor microenvironment (25).